Risk factors and differential diagnosis of Alzheimer's disease

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL. 3, 1999, Pages

  Muller Spahn F ^a   Hock, C ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NONE

Author keywords

Dementia; Depression; Risk genes

Indexed keywords

AGE; ALZHEIMER DISEASE; BRAIN DYSFUNCTION; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 21; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037652979     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014172     Document Type: Conference Paper

References (38)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (1994) Washington, DC
2. Beyreuther K, Pollwein P, Multhaup G, Monning U, Konig G, Dyrks T, Schubert W, Masters CL (1993) Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann N Y Acad Sci 695 : 91-102
3. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19(4) : 357-360
4. Bouchard RW and Rossor M (1996) Typical clinical features. In: Gauthier S (ed) Clinical diagnosis and management of Alzheimer's disease. Martin Dunitz, London: pp 35-50
5. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42(3 Pt 1) : 473-480
6. Clinical and neuropathological criteria for frontotemporal dementia (1994) The Lund and Manchester groups. J Neurol Neurosurg Psychiatry 57 : 416-418
7. Corder EH, Saunders AM, Strittmatter WJ, et al. (1993) Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families. Science 261 : 921-923
8. Crook T, Bartus RT, Ferris SH, et al. (1986) Age-Associated Memory Impairments: Proposed diagnostic criteria and measurs of clinical change - reports of a National Institute of Mental Health Study Group. Dev Neuropsychol 2(4) : 261-276
9. Cummings JL and Khachaturian Z (1996) Definitions and diagnostic criteria. In: Gauthier S (ed) Clinical diagnosis and management of Alzheimer's disease. Martin Dunitz, London: pp 3-15
10. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) Amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38(11) : 1688-1693
11. Folstein MF, Folstein SE & McHugh PR (1975) "Mini Mental State" - A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 : 189-198
12. Freedman M, Leach L, Kaplan E, Winocur G, Shulman KI. & Delis DC. (1994) Clock Drawing: A neuropsychological analysis. New York, Oxford: Oxford University Press
13. Hock C, Müller-Spahn F (1999) Risikofaktoren der Alzheimer Demenz. In: Helmchen H, Henn FA, Lauter H (eds) Psychiatrie der Gegenwart, Band "Organische Störungen". Springer Verlag (in press)
14. Hock C (1998) Biological Markers of Alzheimer's Disease. Neurobiol Aging 19(2) : 149-151
15. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for staging of dementia. British Journal of Psychiatry 140 : 566-572
16. Hyman Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, Staehelin H, Growdon JH, Tanzi RE, Hyman BT (1998) Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet 7(12) : 1953-1956
17. ICD-10 (1991) Weltgesundheitsorganisation, Internationale Klassifikation psychischer Störungen, Hrsg. H. Dilling, W. Mombour, M.H. Schmidt, Verlag H. Huber, Göttingen
18. Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24(1) : 145-153
19. Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: A quantitative integration of the literature. Acta Psych Scand 76 : 465-479
20. Kaye JA (1998) Diagnostic challenges in dementia. Neurology 51(S1) : S 45-52
21. Locascio JJ, Growdon JH, Corkin S (1995) Cognitive test performance in detecting, staging, and tracking Alzheimer's disease. Arch Neurol 52(11) : 1087-1099
22. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology47(5) : 1113-1124
23. McKhann G et al (1984) Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force in Alzheimer's Disease. Neurology 34 : 939-944
24. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, & CERAD investigators (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 : 1159-1165
25. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. BMJ 310 : 970-973
26. Pfeffer RI, Kurosaki TT, Harrah CH JR, Chance JM, Filos S (1982) Measurement of functional activities in older adults in the community. J Gerontol 37(3) : 323-329
27. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320(22) : 1446-1452
28. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43(8) : 1467-1472
29. Selkoe DJ (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 10 : 373-403
30. Schnider A (1997) Verhaltensneurologie: die neurologische Seite der Neuropsychologie. Thieme, Stuttgart; New York
31. Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L (1995) Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 38(1) : 124-127
32. Spiegel R, Brunner C, Ermini-Funfschilling D, Monsch A, Notter M, Puxty J, Tremmel L (1991) A new behavioral assessment scale for geriatric out-and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). J Am Geriatr Soc 39(4) : 339-347
33. Stähelin HB, Monsch AU, Spiegel R (1997). Early diagnosis of dementia via a two-step screening and diagnostic procedure. International Psychogeriatrics, 9 (Suppl. 1), 123-130
34. Stähelin HB et al. (1999) Diagnostik und Therapie der Alzhemer Krankheit - Ein Konsensus für die Schweiz. Schweizerische Ärztezeitung, im Druck
35. Thalmann B, Monsch AU, Ermini-Fünfschilling D, Stähelin HB, Spiegel R (1997) Zeitzeich(n)en: Demenzscreening in der hausärztlichen Praxis. Geriatrie Praxis 8(2) : 31-32
36. Van Broeckhoven CL (1995) Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol 35(1) : 8-19
37. Wurtman RJ (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends-Neurosci 15(4) : 117-122
38. Yoshitake T, Kiyohara Y, Kato I, et al. (1995) Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 45 : 1161-1168